Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. (Q43153223)
Jump to navigation
Jump to search
scientific article published on 23 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. |
scientific article published on 23 February 2010 |
Statements
1 reference
Bevacizumab improves pathological response of colorectal cancer liver metastases treated with XELOX/FOLFOX. (English)
1 reference
1 reference
Markus Klinger
1 reference
Dietmar Tamandl
1 reference
Sandra Eipeldauer
1 reference
Beata Herberger
1 reference
Klaus Kaczirek
1 reference
Marion Dorfmeister
1 reference
Birgit Gruenberger
1 reference
Thomas Gruenberger
1 reference
23 February 2010
1 reference
1 reference
17
1 reference
8
1 reference
2059-2065
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference